Literature DB >> 9606811

CD95-induced apoptosis in human liver disease.

P R Galle1, P H Krammer.   

Abstract

The CD95 receptor is a death receptor capable of transducing apoptotic cell death upon ligation with the CD95 ligand (CD95L). The CD95/CD95L system plays a physiological role in apoptosis of lymphocytes and liver cells. In addition, the striking finding of acute hepatic failure in mice upon CD95 triggering has stimulated general interest in the involvement of CD95 mediated apoptosis in human liver disease. The currently available data point to a deregulated CD95 system in viral hepatitis, alcoholic hepatitis, acute hepatic failure of different etiology, diseases of the bile ducts, and hepatocellular carcinoma. Animal experiments suggest a causative relationship between CD95 activation and liver cell death, which, however, still has to be proven for liver disease in man. This review summarizes our present knowledge on CD95 mediated human liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606811     DOI: 10.1055/s-2007-1007150

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  18 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl4 -induced fibrosis but not steatosis or inflammation.

Authors:  Sanjoy Roychowdhury; Dian J Chiang; Palash Mandal; Megan R McMullen; Xiuli Liu; Jessica I Cohen; John Pollard; Ariel E Feldstein; Laura E Nagy
Journal:  Alcohol Clin Exp Res       Date:  2012-01-24       Impact factor: 3.455

3.  Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Authors:  Arndt Vogel; Joseph E Aslan; Holger Willenbring; Christian Klein; Milton Finegold; Howard Mount; Gary Thomas; Markus Grompe
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

4.  FADD and TRADD expression and apoptosis in primary hepatocellular carcinoma.

Authors:  Bao-Hua Sun; Xi-Ping Zhao; Bao-Ju Wang; Dong-Liang Yang; Lian-Jie Hao
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

5.  Study on Fas/Fas-L expression in liver tissue and hepatocyte apoptosis in patients with hepatitis gravis.

Authors:  Q Xia; S Shi
Journal:  J Tongji Med Univ       Date:  2001

6.  Regulation of Aspartyl-(Asparaginyl)-β-Hydroxylase Protein Expression and Function by Phosphorylation in Hepatocellular Carcinoma Cells.

Authors:  Diana L Borgas; Jin-Song Gao; Ming Tong; Nitin Roper; Suzanne M de la Monte
Journal:  J Nat Sci       Date:  2015-04-01

7.  Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.

Authors:  Weina Chen; Chang Han; Jinqiang Zhang; Kyoungsub Song; Ying Wang; Tong Wu
Journal:  Am J Pathol       Date:  2015-04       Impact factor: 4.307

8.  The strength of the Fas ligand signal determines whether hepatocytes act as type 1 or type 2 cells in murine livers.

Authors:  Sven Schüngel; Laura Elisa Buitrago-Molina; Padmavathi devi Nalapareddy; Margitta Lebofsky; Michael P Manns; Hartmut Jaeschke; Atan Gross; Arndt Vogel
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

9.  miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 Receptor.

Authors:  Ximena V Qadir; Weina Chen; Chang Han; Kyoungsub Song; Jinqiang Zhang; Tong Wu
Journal:  Am J Pathol       Date:  2015-12       Impact factor: 4.307

10.  Apoptosis and cytokines in non-alcoholic steatohepatitis.

Authors:  Wing-Kin Syn; Steve S Choi; Anna Mae Diehl
Journal:  Clin Liver Dis       Date:  2009-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.